Abstract
At risk patients undergoing cardiac surgery with cardiopulmonary bypass have increased rates of postoperative infectious morbidity. Postoperatively, after cardiac surgery, an immunosuppression in the form of a polarization of T helper (Th) cells with a decreased Th1 response (IL-2 and IFN-γ) and an increased Th2 response (IL-4 and IL-10) is recognized. Therapeutic strategies to modulate the immunological response include special key nutrients such as the amino acid glutamine favoring the Th2 response. There is no information available concerning its effect in patients undergoing cardiac surgery. The aim of this clinical study was to evaluate the effects of a perioperative infusion of glutamine on the polarized lymphocyte T cell cytokine expression and on infectious morbidity in cardiac surgery patients at risk of infection. Seventy-eight patients were included in the study undergoing elective cardiac surgery with a lymphopenia less than 1.2 giga/l. One or more of the following criteria had to be met: age older than 70 years, ejection fraction less than 40%, or mitral valve replacement. We randomly assigned patients to receive infusions of either high-dose l-alanyl-l-glutamine dipeptide [0.5 g/(kg day) glutamine] dissolved in an amino acid solution or an isonitrogeneous, isocaloric, isovolemic nutritional solution. An additional group with normal saline served as control to eliminate any nonspecific nutritional effect. We started the infusion after induction of anesthesia with 1,000 ml/24 h and continued it for 3 days. The primary endpoint was intracellular T cell cytokine expression (including the description in tertiles) on the first postoperative day (pod 1). Secondary endpoints were postoperative infection rate, mortality rate, cardiovascular circulation ventilation time, and renal function. A high-dose perioperative glutamine application leading to mean plasma levels of 1,177 μM had only a minor influence on the polarized intracellular T cell cytokine expression. On pod 1 there was a polarization of T cells, i.e., an augmented Th2 response with an increased number of IL-6 and IL-10 producing cells. On the other side the Th1 response with IL-2 and TNF-α declined on pods 1 and 2. Only the intracellular IL-2 response in the lower tertile of IL-2 production was improved with glutamine indicating a small influence. We did not observe any effects on the numbers of postoperative infections; on mortality rate; on cardiovascular circulation; on ventilation time or on renal function. The elevation of glutamine plasma levels by a perioperative intravenous infusion of l-alanyl-l-glutamine influenced the intracellular expression of IL-2 in the lower tertile only slightly. However, mean glutamine values in the other groups remained above or close 500 μM, thus suggesting that glutamine supply to the immune cells was still adequate in most patients, and that glutamine deficiency, if it occurred, was marginal. In the event of a severe glutamine deficiency the observed effect on cytokine production could be more pronounced. Furthermore, we could not observe any obvious clinical advantage in this at risk cardiac surgical patient population. A glutamine supplementation for patients undergoing cardiac surgery without a clear glutamine deficiency is not recommended.
Similar content being viewed by others
References
Bossuyt X, Marti GE, Fleisher TA (1997) Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry 30:124–133
Coeffier M, Claeyssens S, Hecketsweiler B, Lavoinne A, Ducrotte P, Dechelotte P (2003) Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. Am J Physiol Gastrointest Liver Physiol 285:G266–G273
Dechelotte P, Hasselmann M, Cynober L, Allaouchiche B, Coeffier M, Hecketsweiler B, Merle V, Mazerolles M, Samba D, Guillou YM, Petit J, Mansoor O, Colas G, Cohendy R, Barnoud D, Czernichow P, Bleichner G (2006) l-Alanyl-l-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 34:598–604
Engel JM, Mühling J, Weiss S, Lohr T, Simonis Y, Menges T, Hempelmann G (2003) Low plasma glutamine after multiple trauma: relationship with intracellular glutamine in polymorphonuclear neutrophils during prolonged ICU stay. Acta Anaesthesiol Scand 47:707–713
Furst P (2001) New developments in glutamine delivery. J Nutr 131:2562S–2568S
Garcia-de-Lorenzo A, Zarazaga A, Garcia-Luna PP, Gonzalez-Huix F, Lopez-Martinez J, Mijan A, Quecedo L, Casimiro C, Usan L, del Llano J (2003) Clinical evidence for enteral nutritional support with glutamine: a systematic review. Nutrition 19:805–811
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16:128–140
Griffiths RD, Allen KD, Andrews FJ, Jones C (2002) Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 18:546–552
Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P (2003) Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 27:355–373
Heyland DK, Dhaliwalm R, Day A, Drover J, Cote H, Wischmeyer P (2007) Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN J Parenter Enteral Nutr 31:109–118
Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, Teerlink T, Meuwissen SG, Haarman HJ, Thijs LG, van Leeuwen PA (1998) Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 352:772–776
Iwasaka H, Noguchi T (2004) Th1/Th2 balance in systemic inflammatory response syndrome (SIRS). Nippon Rinsho 62:2237–2243
Jensen GL, Miller RH, Talabiska DG, Fish J, Gianferante L (1996) A double-blind, prospective, randomized study of glutamine-enriched compared with standard peptide-based feeding in critically ill patients. Am J Clin Nutr 64:615–621
Laffey JG, Boylan JF, Cheng DCH (2002) The systemic inflammatory response to cardiac surgery. Implications for the anesthesiologist. Anesthesiology 97:215–252
Lai YN, Yeh SL, Lin MT, Shang HF, Yeh CL, Chen WJ (2004) Glutamine supplementation enhances mucosal immunity in rats with gut-derived sepsis. Nutrition 20:286–291
Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B (1993a) Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg 105:15–24
Markewitz A, Grabein B, Abel S, Nolleret G, Kreuzer E, Reichart B (1993b) Erregerspektrum und Resistenzmuster auf einer herzchirurgischen Intensivstation. Intensivmedizin 30:441
Markewitz A, Faist E, Lang S, Hultner L, Weinhold C, Reichart B (1996) An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg 10:61–67
Mühling J, Fuchs M, Dehne MG, Sablotzki A, Menges T, Weber B, Hempelmann G (1999) Quantitative determination of free intracellular amino acids in single human polymorphonuclear leucocytes. Recent developments in sample preparation and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 728:157–166
Muret J, Marie C, Fitting C, Payen D, Cavaillon JM (2000) Ex vivo T-lymphocyte derived cytokine production in SIRS patients is influenced by experimental procedures. Shock 13:169–174
Murphy T, Paterson H, Rogers S, Mannick JA, Lederer JA (2003) Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients. Ann Surg 238:401–410
Newsholme P (2001) Why is l-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 131:2515S–2522S
Newsholme EA, Calder PC (1997) The proposed role of glutamine in some cells of the immune system and speculative consequences for the whole animal. Nutrition 13:728–730
Newsholme EA, Parry-Billings M (1990) Properties of glutamine release from muscle and its importance for the immune system. JPEN J Parenter Enteral Nutr 14:63S–67S
Novak F, Heyland DK, Avenell A, Drover JW, Su X (2002) Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30:2022–2029
Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF (2001) Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 27:84–90
Rohde T, MacLean DA, Klarlund PB (1996) Glutamine, lymphocyte proliferation and cytokine production. Scand J Immunol 44:648–650
Romagnani S (1997) The Th1/Th2 paradigm. Immunol Today 18:263–266
Romagnani S (2000) T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 85:9–18
Roth E, Funovics J, Muhlbacher F, Schemper M, Mauritz W, Sporn P, Fritsch A (1982) Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr 1:25–41
Tapiero H, Mathe G, Couvreur P, Tew KD (2002) II: Glutamine and glutamate. Biomed Pharmacother 56:446–457
Tepaske R, Velthuis H, Oudemans-van Straaten HM, Heisterkamp SH, van Deventer SJ, Ince C, Eysman L, Kesecioglu J (2001) Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 358:696–701
van der Hulst RR, van Kreel BK, von Meyenfeldt MF, Brummer RJ, Arends JW, Deutz NE, Soeters PB (1993) Glutamine and the preservation of gut integrity. Lancet 341:1363–1365
Wasa M, Wang HS, Okada A (2002) Characterization of l-glutamine transport by a human neuroblastoma cell line. Am J Physiol Cell Physiol 282:C1246–C1253
Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L, Kahana M (2001) Glutamine administration reduces gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 29:2075–2080
Wischmeyer PE, Riehm J, Singleton KD, Ren H, Musch MW, Kahana M, Chang EB (2003) Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 19:1–6
Yaqoob P, Calder PC (1997) Glutamine requirement of proliferating T lymphocytes. Nutrition 13:646–651
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Engel, J.M., Ruhs, S., Mühling, J. et al. Perioperative application of l-alanyl-l-glutamine in cardiac surgery: effect on the polarized T cell cytokine expression. Amino Acids 36, 519–527 (2009). https://doi.org/10.1007/s00726-008-0114-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-008-0114-x